TriSalus Life Sciences (TLSI) Current Assets (2020 - 2026)

TriSalus Life Sciences' Current Assets history runs 7 years deep, the most recent figure standing at $68.1 million for Q1 2026.

• On a quarterly basis, Current Assets rose 171.51% year-over-year to $68.1 million in Q1 2026; TTM through Mar 2026 was $68.1 million, a 171.51% increase from a year earlier, with the FY2025 full-year figure at $32.2 million, up 56.0% from the prior year.
• Current Assets climbed to $68.1 million in Q1 2026 per TLSI's latest filing, from $32.2 million in the prior quarter.
• Across five years, Current Assets topped out at $68.1 million in Q1 2026 and bottomed at $161454.0 in Q2 2023.
• The 5-year median for Current Assets is $20.9 million (2023), against an average of $20.6 million.
• Across the five-year window, Current Assets slumped 80.26% in 2022 and surged 17205.86% in 2024, its largest moves.
• Year by year, Current Assets stood at $17.2 million in 2022, then gained by 21.19% to $20.9 million in 2023, then dropped by 0.93% to $20.7 million in 2024, then soared by 56.0% to $32.2 million in 2025, then jumped by 111.32% to $68.1 million in 2026.
• Per Business Quant, the three latest TLSI Current Assets figures stand at $68.1 million (Q1 2026), $32.2 million (Q4 2025), and $33.3 million (Q3 2025).